Practical allergy (PRACTALL) report: risk assessment in anaphylaxis.
Effector mechanisms in anaphylaxis were reviewed. Current approaches to confirmation of the clinical diagnosis were discussed. Improved methods for distinguishing between allergen sensitization (which is common in the general population) and clinical risk of anaphylaxis (which is uncommon) were deliberated. Innovative techniques that will improve risk assessment in anaphylaxis in the future were described.
Simons
F E R
FE
Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, Canada.
Frew
A J
AJ
Ansotegui
I J
IJ
Bochner
B S
BS
Golden
D B K
DB
Finkelman
F D
FD
Leung
D Y M
DY
Lotvall
J
J
Marone
G
G
Metcalfe
D D
DD
Müller
U
U
Rosenwasser
L J
LJ
Sampson
H A
HA
Schwartz
L B
LB
van Hage
M
M
Walls
A F
AF
D000707:Anaphylaxis / Q000175:diagnosis*; D003245:Consensus Statements as Topic; D005060:Europe; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis; D008297:Male; D017410:Practice Guidelines as Topic / Q000592:standards*; D011379:Prognosis; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D014481:United States